Wall Street Zen upgraded shares of Cardlytics (NASDAQ:CDLX – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday morning.
A number of other research analysts also recently issued reports on CDLX. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a research note on Wednesday, July 8th. Lake Street Capital set a $10.00 price objective on Cardlytics in a research note on Friday, May 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Sell” and an average target price of $10.00.
Check Out Our Latest Report on Cardlytics
Cardlytics Price Performance
Cardlytics (NASDAQ:CDLX – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($1.50) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.30) by $0.80. The company had revenue of $36.88 million during the quarter, compared to the consensus estimate of $37.00 million. Cardlytics had a negative net margin of 55.92% and a negative return on equity of 956.56%. As a group, equities analysts expect that Cardlytics will post -1.1 EPS for the current fiscal year.
Insider Transactions at Cardlytics
In related news, CEO Amit Gupta sold 9,640 shares of the company’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $4.39, for a total transaction of $42,319.60. Following the transaction, the chief executive officer owned 113,850 shares of the company’s stock, valued at approximately $499,801.50. This represents a 7.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO David Thomas Evans purchased 15,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was acquired at an average cost of $6.50 per share, for a total transaction of $97,500.00. Following the completion of the purchase, the chief financial officer owned 26,793 shares in the company, valued at $174,154.50. The trade was a 127.19% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders sold 18,289 shares of company stock valued at $80,289. 5.90% of the stock is currently owned by corporate insiders.
Institutional Trading of Cardlytics
Institutional investors and hedge funds have recently bought and sold shares of the business. Sender Co & Partners Inc. purchased a new position in Cardlytics in the third quarter valued at about $210,000. Invesco Ltd. boosted its position in shares of Cardlytics by 38.1% in the fourth quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock worth $196,000 after buying an additional 46,973 shares during the period. XTX Topco Ltd boosted its position in shares of Cardlytics by 143.5% in the second quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock worth $141,000 after buying an additional 50,663 shares during the period. Centiva Capital LP acquired a new stake in shares of Cardlytics in the third quarter valued at about $104,000. Finally, Algert Global LLC acquired a new stake in shares of Cardlytics in the third quarter valued at about $100,000. Institutional investors and hedge funds own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Featured Stories
- Five stocks we like better than Cardlytics
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
